Bone mineral content in normally menstruating women with hyperprolactinaemia. 1988

E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
Department of Medicine II, Sahlgren's Hospital, Göteborg, Sweden.

Decreased bone density has been reported in women with hyperprolactinaemia due to pituitary tumours. We identified a number of seemingly healthy women with hyperprolactinaemia, i.e. a serum prolactin concentration exceeding 500 mU/l (25 micrograms/l) on three occasions, during a study in 1980/1981 of a representative population sample of greater than 1,400 women in seven different age strata (range 26-72 years). We compared vertebral bone mineral content and bone mineral areal content in 5 hyperprolactinaemic normally menstruating 50-year-old women with that of 6 controls matched for age and menstrual status but found no difference. Since the degree of prolactin elevation was similar in our study group to that previously reported for hyperprolactinaemic subjects with pituitary tumours and the time of exposure to raised hormone concentration appears to be of the same magnitude, other hormonal changes than hyperprolactinaemia per se seem to be the cause of low bone mineral content in women with hyperprolactinaemia and amenorrhoea.

UI MeSH Term Description Entries
D006966 Hyperprolactinemia Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8) Prolactin Hypersecretion Syndrome,Prolactin, Inappropriate Secretion,Hyperprolactinaemia,Inappropriate Prolactin Secretion,Inappropriate Prolactin Secretion Syndrome,Hyperprolactinemias,Hypersecretion Syndrome, Prolactin,Inappropriate Secretion Prolactin,Prolactin Secretion, Inappropriate,Secretion Prolactin, Inappropriate,Secretion, Inappropriate Prolactin,Syndrome, Prolactin Hypersecretion
D008598 Menstruation The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008903 Minerals Native, inorganic or fossilized organic substances having a definite chemical composition and formed by inorganic reactions. They may occur as individual crystals or may be disseminated in some other mineral or rock. (Grant & Hackh's Chemical Dictionary, 5th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Mineral
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females

Related Publications

E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
October 2002, Journal of the American College of Nutrition,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
January 1974, European journal of obstetrics, gynecology, and reproductive biology,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
May 1989, Annals of the Academy of Medicine, Singapore,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
August 2015, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
October 1990, Medicine and science in sports and exercise,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
January 1980, Acta medica Scandinavica,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
July 1994, The American journal of cardiology,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
February 1997, Indian journal of medical sciences,
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
January 1987, British medical journal (Clinical research ed.),
E Nyström, and J Leman, and P A Lundberg, and O Lindquist, and T Hansson, and C Bengtsson, and G Rybo, and G Lindstedt
May 1980, Acta endocrinologica,
Copied contents to your clipboard!